One Step to a Cure Outcomes of Experimental Treatments for Non-Hodgkins Lymphomas, A Systematic Review

G. A. Neto, Maria L. Cascudo
{"title":"One Step to a Cure Outcomes of Experimental Treatments for Non-Hodgkins Lymphomas, A Systematic Review","authors":"G. A. Neto, Maria L. Cascudo","doi":"10.34257/gjmrfvol23is5pg33","DOIUrl":null,"url":null,"abstract":"Non-Hodgkins lymphomas are malignant lymphatic tumors, mainly affecting B cells. Generally occur in children and young adults with different forms of treatment, however most treatments are accompanied by tumoral relapse.Recently, many researches have been made to identify the best treatment with positive long-term outcomes. In that regard, CAR-T cell treatment has been recognized for its accessibility and effect, it utilizes T cells with chimeric antigen receptors, facilitating cancerous cells detection after non-response to the regular R-CHOP treatment. As data-base 26 research papers were found, with 23 of them being utilized.","PeriodicalId":93101,"journal":{"name":"Global journal of medical research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global journal of medical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34257/gjmrfvol23is5pg33","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Non-Hodgkins lymphomas are malignant lymphatic tumors, mainly affecting B cells. Generally occur in children and young adults with different forms of treatment, however most treatments are accompanied by tumoral relapse.Recently, many researches have been made to identify the best treatment with positive long-term outcomes. In that regard, CAR-T cell treatment has been recognized for its accessibility and effect, it utilizes T cells with chimeric antigen receptors, facilitating cancerous cells detection after non-response to the regular R-CHOP treatment. As data-base 26 research papers were found, with 23 of them being utilized.
迈向治愈非霍奇金淋巴瘤实验治疗结果的一步,一项系统综述
非霍奇金淋巴瘤是一种恶性淋巴肿瘤,主要影响B细胞。通常发生在儿童和年轻人身上,接受不同形式的治疗,但大多数治疗都伴有肿瘤复发。最近,已经进行了许多研究来确定具有积极长期结果的最佳治疗方法。在这方面,CAR-T细胞治疗因其可及性和效果而得到认可,它利用具有嵌合抗原受体的T细胞,促进对常规R-CHOP治疗无反应后癌细胞的检测。作为数据库,发现了26篇研究论文,其中23篇正在使用中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信